BMJ Case Reports 2013; doi:10.1136/bcr-2013-008960

Autologous human cardiac stem cells transplantation for the treatment of ischaemic cardiomyopathy: first study of human-induced pluripotent stem (iPS) cell-derived cardiomyocytes transplantation

  1. Joren Madson2
  1. 1Reprogramming Inc, Chiba, Japan
  2. 2Reprogramming Inc, Boston, Massachusetts, USA
  1. Correspondence to Dr Hisashi Moriguchi, moriguchi-tky{at}


Temporarily withdrawn while we investigate a complaint.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article